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eLife’s	transparent	reporting	form	
	
We	encourage	authors	to	provide	detailed	information	within	their	submission	to	facilitate	
the	interpretation	and	replication	of	experiments.	Authors	can	upload	supporting	
documentation	to	indicate	the	use	of	appropriate	reporting	guidelines	for	health-related	
research	(see	EQUATOR	Network),	life	science	research	(see	the	BioSharing	Information	
Resource),	or	the	ARRIVE	guidelines	for	reporting	work	involving	animal	research.	Where	
applicable,	authors	should	refer	to	any	relevant	reporting	standards	documents	in	this	form.	
	
If	you	have	any	questions,	please	consult	our	Journal	Policies	and/or	contact	us:	
editorial@elifesciences.org.	
	
Sample-size	estimation	
• You	should	state	whether	an	appropriate	sample	size	was	computed	when	the	
study	was	being	designed		
• You	should	state	the	statistical	method	of	sample	size	computation	and	any	
required	assumptions	
• If	no	explicit	power	analysis	was	used,	you	should	describe	how	you	decided	what	
sample	(replicate)	size	(number)	to	use	
	
Please	outline	where	this	information	can	be	found	within	the	submission	(e.g.,	sections	or	
figure	legends),	or	explain	why	this	information	doesn’t	apply	to	your	submission:	
	
Replicates	
• You	should	report	how	often	each	experiment	was	performed	
• You	should	include	a	definition	of	biological	versus	technical	replication	
• The	data	obtained	should	be	provided	and	sufficient	information	should	be	
provided	to	indicate	the	number	of	independent	biological	and/or	technical	
replicates	
• If	you	encountered	any	outliers,	you	should	describe	how	these	were	handled	
• Criteria	for	exclusion/inclusion	of	data	should	be	clearly	stated	
• High-throughput	sequence	data	should	be	uploaded	before	submission,	with	a	
private	link	for	reviewers	provided	(these	are	available	from	both	GEO	and	
ArrayExpress)	
	
Please	outline	where	this	information	can	be	found	within	the	submission	(e.g.,	sections	or	
figure	legends),	or	explain	why	this	information	doesn’t	apply	to	your	submission:	
	
	 	
All	details	related	to	sample	size	are	detailed	in	the	“materials	and	methods”	
section.	
In	addition,	we	include	a	table	(Table	1)	which	indicates	the	number	of	
individuals	used	for	each	experiment.	
No	explicit	power	analysis	was	used	as	the	results	were	relatively	consistent	
between	samples.		
In	the	“materials	and	methods”	section,	and	in	table	1	we	describe	the	number	
of	replicates,	and	the	criteria	used	to	exclude	samples,	if	applicable.		
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Statistical	reporting	
• Statistical	analysis	methods	should	be	described	and	justified	
• Raw	data	should	be	presented	in	figures	whenever	informative	to	do	so	(typically	
when	N	per	group	is	less	than	10)	
• For	each	experiment,	you	should	identify	the	statistical	tests	used,	exact	values	of	
N,	definitions	of	center,	methods	of	multiple	test	correction,	and	dispersion	and	
precision	measures	(e.g.,	mean,	median,	SD,	SEM,	confidence	intervals;	and,	for	the	
major	substantive	results,	a	measure	of	effect	size	(e.g.,	Pearson's	r,	Cohen's	d)	
• Report	exact	p-values	wherever	possible	alongside	the	summary	statistics	and	95%	
confidence	intervals.	These	should	be	reported	for	all	key	questions	and	not	only	
when	the	p-value	is	less	than	0.05.	
	
Please	outline	where	this	information	can	be	found	within	the	submission	(e.g.,	sections	or	
figure	legends),	or	explain	why	this	information	doesn’t	apply	to	your	submission:	
	
(For	large	datasets,	or	papers	with	a	very	large	number	of	statistical	tests,	you	may	upload	a	
single	table	file	with	tests,	Ns,	etc.,	with	reference	to	sections	in	the	manuscript.)	
	
Group	allocation	
• Indicate	how	samples	were	allocated	into	experimental	groups	(in	the	case	of	
clinical	studies,	please	specify	allocation	to	treatment	method);	if	randomization	
was	used,	please	also	state	if	restricted	randomization	was	applied	
• Indicate	if	masking	was	used	during	group	allocation,	data	collection	and/or	data	
analysis	
	
Please	outline	where	this	information	can	be	found	within	the	submission	(e.g.,	sections	or	
figure	legends),	or	explain	why	this	information	doesn’t	apply	to	your	submission:	
	
Additional	data	files	(“source	data”)	
• We	encourage	you	to	upload	relevant	additional	data	files,	such	as	numerical	data	
that	are	represented	as	a	graph	in	a	figure,	or	as	a	summary	table	
• Where	provided,	these	should	be	in	the	most	useful	format,	and	they	can	be	
uploaded	as	“Source	data”	files	linked	to	a	main	figure	or	table	
• Include	model	definition	files	including	the	full	list	of	parameters	used	
• Include	code	used	for	data	analysis	(e.g.,	R,	MatLab)	
• Avoid	stating	that	data	files	are	“available	upon	request”	
	
Please	indicate	the	figures	or	tables	for	which	source	data	files	have	been	provided:	
	
All	the	numerical	data	in	the	paper	is	summarized	in	table	1.	
All	numerical	data	are	presented	as	mean	+-SD.	
The	experiments	involved	measuring	the	distribution	and	number	of	cells	connected	to	
different	types	of	“donor”	neurons-	the	controls	had	no	cells	labeled	at	all.		
Samples	were	allocated	into	experimental	or	control	groups	depending	on	the	
genotype	of	the	animals	studied.	
All	available	data	is	reported	in	the	ms.	
